CLIA Waiver Authority Shifts To FDA; IVD Office Ready To Test New Methods

CDRH is encouraging manufacturers to work with its in vitro diagnostics office to pilot new ways to meet CLIA waiver criteria

More from Archive

More from Medtech Insight